• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71020
Device Problem Insufficient Information (3190)
Patient Problem Pain (1994)
Event Date 09/11/2023
Event Type  Injury  
Manufacturer Narrative
Xray imaging was taken at the local emergency department during the patient's pain event, however those images were not made available to the firm for evaluation of the placement of the nalu system components.After receiving medication, the patient reported continuing to receive pain relief from the nalu system.Based on the patient feedback of continuing to receive therapy, it appears that the nalu system was continuing to function appropriately and likely remained in place with minimal or no migration.Nalu staff were not present for the system explant as no notification was provided prior to the procedure.The explanted components were discarded by the medical facility during the procedure and thus unavailable for inspection and investigation of the device.
 
Event Description
Patient was implanted with the nalu peripheral nerve stimulator on (b)(6) 2023 to treat lower back pain.Patient reported receiving pain relief therapy after the system was activated.Approximately three months after activation the patient was traveling and noted a sudden onset of pain, beginning in the arms and spreading across the entire body.Patient reports pain was severe enough to cause impaired mobility.Patient was taken by emergency medical services to the local emergency department for evaluation.Patient was given muscle relaxers and pain medication and advised to contact the primary physician.After being evaluated, the patient reports using the nalu system only for brief periods while doing extended periods of walking.The system provided some relief while activated, however the patient was concerned that the sudden pain would recur and requested to have the nalu system removed.A full system explant was performed on (b)(6) 2023.Nalu was made aware of the event and subsequent explant on (b)(6) 2023 when the patient reported the event to the firm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad
Manufacturer Contact
terry villarba
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key18116824
MDR Text Key327881426
Report Number3015425075-2023-00274
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00812537036182
UDI-Public01008125370361821122082517250825
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number71020
Device Catalogue Number71020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/25/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-